Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$5.51
NASDAQLPCN
Open
$6.00
Change
-$0.31 (-5.33%)
Day's Range
$5.51 - $6.00
52-Week Range
$2.31 - $11.79
Volume
15.0K
Market Cap
$29.5M
Currency in USD.
Quote data delayed by at least 15 minutes.